New-onset Parkinson syndrome after liver transplantation.

Rifaie N, Koeppen S, Treckmann JW, Paul A, Saner FH.

Transplantation. 2012 Oct 27;94(8):e56-7. doi: 10.1097/TP.0b013e31826b85c9. No abstract available.

Elevated pontine and putamenal GABA levels in mild-moderate Parkinson disease detected by 7 tesla proton MRS.

Emir UE, Tuite PJ, Öz G.

PLoS One. 2012;7(1):e30918. doi: 10.1371/journal.pone.0030918.

Assessment of the effects of unilateral electrode dysfunction in patients with Parkinson disease undergoing bilateral subthalamic nucleus deep brain stimulation.

Park YS, Kim JP, Chang WS, Lee PH, Sohn YH, Chang JW.

Neurosurgery. 2012 Mar;70(1 Suppl Operative):163-9; discussion 169. doi: 10.1227/NEU.0b013e31822d5d4c.

Genetic variation in LINGO-1 (rs9652490) and risk of Parkinson's disease: twelve studies and a meta-analysis.

Wu Y, Wang X, Xu W, Liu W, Fang F, Ding J, Song Y, Chen S.

Neurosci Lett. 2012 Jul 26;522(1):67-72. doi: 10.1016/j.neulet.2012.06.018.

Are selective serotonin reuptake inhibitors associated with greater apathy in Parkinson's disease?

Zahodne LB, Bernal-Pacheco O, Bowers D, Ward H, Oyama G, Limotai N, Velez-Lago F, Rodriguez RL, Malaty I, McFarland NR, Okun MS.

J Neuropsychiatry Clin Neurosci. 2012 Summer;24(3):326-30. doi: 10.1176/appi.neuropsych.11090210.

Prospective outcome of rapid eye movement sleep behaviour disorder: psychiatric disorders as a potential early marker of Parkinson's disease.

Wing YK, Li SX, Mok V, Lam SP, Tsoh J, Chan A, Yu MW, Lau CY, Zhang J, Ho CK.

J Neurol Neurosurg Psychiatry. 2012 Apr;83(4):470-2. doi: 10.1136/jnnp-2011-301232. No abstract available.

The effect of supervised exercises on static and dynamic balance in Parkinson's disease patients.

Kara B, Genc A, Colakoglu BD, Cakmur R.

NeuroRehabilitation. 2012;30(4):351-7. doi: 10.3233/NRE-2012-0766.

Diffusion tensor imaging in elderly patients with idiopathic normal pressure hydrocephalus or Parkinson's disease: diagnosis of gait abnormalities.

Marumoto K, Koyama T, Hosomi M, Kodama N, Miyake H, Domen K.

Fluids Barriers CNS. 2012 Sep 18;9(1):20. doi: 10.1186/2045-8118-9-20.

Curcumin-glucoside, a novel synthetic derivative of curcumin, inhibits α-synuclein oligomer formation: relevance to Parkinson's disease.

Gadad BS, Subramanya PK, Pullabhatla S, Shantharam IS, Rao KS.

Curr Pharm Des. 2012;18(1):76-84.

Iowa Gambling Task in patients with early-onset Parkinson's disease: strategy analysis.

Gescheidt T, Czekóová K, Urbánek T, Mareček R, Mikl M, Kubíková R, Telecká S, Andrlová H, Husárová I, Bareš M.

Neurol Sci. 2012 Dec;33(6):1329-35. doi: 10.1007/s10072-012-1086-x.

Genetic Screening of the Mitochondrial Rho GTPases MIRO1 and MIRO2 in Parkinson's Disease.

Anvret A, Ran C, Westerlund M, Sydow O, Willows T, Olson L, Galter D, Belin AC.

Open Neurol J. 2012;6:1-5. doi: 10.2174/1874205X01206010001.

Rhes-mTORC1 interaction: a new possible therapeutic target in Parkinson's disease and L-dopa-induced dyskinesia?

Picconi B, Calabresi P.

Mov Disord. 2012 Jun;27(7):815. No abstract available.

Parkinson disease.

Keller DL.

Cleve Clin J Med. 2012 Apr;79(4):242-3; author reply 243, 248. doi: 10.3949/ccjm.79c:04006. No abstract available.

The pill questionnaire in a nondemented Parkinson's disease population.

Reginold W, Armstrong MJ, Duff-Canning S, Lang A, Tang-Wai D, Fox S, Rothberg B, Zadikoff C, Kennedy N, Gill D, Eslinger P, Mapstone M, Chou K, Persad C, Litvan I, Mast B, Marras C.

Mov Disord. 2012 Sep 1;27(10):1308-11. doi: 10.1002/mds.25124.

Neuronal-like differentiation of bone marrow-derived mesenchymal stem cells induced by striatal extracts from a rat model of Parkinson's disease.

Qin X, Han W, Yu Z.

Neural Regen Res. 2012 Dec 5;7(34):2673-80. doi: 10.3969/j.issn.1673-5374.2012.34.004.